Jacobs Levy Equity Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-10,574
| Closed | -$241K | – | 1114 |
|
|
2019
Q4 | $241K | Buy |
10,574
+8,750
| +480% | +$199K | ﹤0.01% | 911 |
|
|
2019
Q3 | $26K | Buy |
+1,824
| New | +$26K | ﹤0.01% | 908 |
|
|
2018
Q3 | – | Sell |
-3,744
| Closed | -$160K | – | 1093 |
|
|
2018
Q2 | $160K | Sell |
3,744
-986
| -21% | -$42.1K | ﹤0.01% | 972 |
|
|
2018
Q1 | $309K | Sell |
4,730
-1,811
| -28% | -$118K | 0.01% | 863 |
|
|
2017
Q4 | $477K | Buy |
6,541
+522
| +9% | +$38.1K | 0.01% | 763 |
|
|
2017
Q3 | $551K | Buy |
6,019
+2,597
| +76% | +$238K | 0.01% | 687 |
|
|
2017
Q2 | $226K | Buy |
3,422
+944
| +38% | +$62.3K | ﹤0.01% | 813 |
|
|
2017
Q1 | $537K | Sell |
2,478
-964
| -28% | -$209K | 0.01% | 655 |
|
|
2016
Q4 | $318K | Buy |
+3,442
| New | +$318K | 0.01% | 758 |
|